Companies Dominating the Topical Pain Relief Landscape
- Johnson & Johnson (USA)
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- GlaxoSmithKline (UK)
- Sanofi (France)
- Pfizer (USA)
- Hisamitsu Pharmaceutical (Japan)
- Bayer (Germany)
- Perrigo (Ireland)
- Sun Pharmaceutical (India)
- Teva Pharmaceutical (Israel)
- Reckitt Benckiser (UK)
- Taisho Pharmaceutical (Japan)
- Cipla (India)
- Hikma Pharmaceuticals (UK)
- Mylan (USA)
- Taro Pharmaceutical (Israel)
- CSPC Pharmaceutical (China)
- Dr. Reddy’s Laboratories (India)
- Endo International (USA)
- Blackmores (Australia)
- Kotra Pharma (Malaysia)
The global players involved in the topical pain relief market are emphasizing the wide range of marketing tactics to enhance their industrial presence across the world. Companies such as Johnson & Johnson, GSK, and Sanofi held a lucrative share of 30.7% in the market. One of the key trends opted by the market players includes product innovation, followed by improved regulatory approvals. Sun Pharma and Cipla are focusing on providing affordable medications in India and Africa, aiming to establish their footprint internationally. Hence, these trends draw the interest of several key players, thereby encouraging a healthy competition in the market.
Here is a list of key players in the global topical pain relief market: